Imaging3, Inc. (OTCMKTS:IGNG) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersItem 5.02 Appointment of Director.
On March 22, 2018 the Company appointed Jeffrey N. Peterson as the Chairman of the Company’s board of directors, effective immediately. Mr. Peterson is currently Chairman of the Board of Directors of Pressure BioSciences, Inc.(OTCQB: PBIO) an Easton, MA. based bioscience tools company. In addition Mr. Peterson is the Board Chairman and CEO of Veritomyx, Inc. a subsidiary of Target Discovery, Inc. of Palo Alto, CA. Prior to his current roles, Mr. Peterson served as CEO of Sharpe, Peterson, Ocheltree & Associates, an international business development consulting firm assisting Fortune 500 and many smaller firms in business expansion and strategy. Mr. Peterson spent 9 years in management roles for Abbott Laboratories, concluding as the CEO & GM of Abbott South Africa. Prior to Abbott, Mr. Peterson spent 11 years rising through management roles for General Electric’s Engineered Materials and Plastics Groups. Mr. Peterson completed the Entepreneurship curriculum and holds BSChemE and MSChemE degrees from MIT. He currently serves on the Advisory Board of the California Technology Council and served for 12 years on the Board of BayBio and is Chair Emeritus of the BayBio Insititute. Mr. Peterson has also served as an active member of the Coalition for the 21st Century Medicine, and in BIO’s Personalized Medicine & Diagnostic Group.
IMAGING3 INC Exhibit…To view the full exhibit click